China’s skyrocketing development of artificial intelligence (AI) will further enhance the country’s digital health industry, GlobalData announced. The new releases of recent AI models Qwen2.5-Max, Kimi k1.5, and DeepSeek v3 demonstrate China’s rising stakes in the arena of AI and its influence... Read More
On January 24, the Korean MFDS made public that it would put together and publish the world’s first Guideline for Approval and Review of Medical Devices Using Generative Artificial Intelligence (AI). To this end, the MFDS has formed a special group of... Read More
Over the last 15 years, China has been good at replicating and making good generic drugs and more sophisticated devices. Over the last few years, with the help of massive investment from the Chinese government and gobs of new local and foreign... Read More
Artificial intelligence is transforming healthcare in Asia: improving the quality of care, facilitating operational efficiency, and increasing patient access. For example, the National University Health System (NUHS) in Singapore uses AI to accurately predict how long patients will stay in the hospital,... Read More
China is rapidly becoming a key driver in the development of precision oncology drugs, facilitated by its rising cancer incidence, proactive government policies, and an influx of biopharma investment. China accounted for nearly a quarter of all global cancer diagnoses, with about 5 million... Read More
Amidst a number of negative healthcare trends in China including competitive locally made products that compete with the West, reduced drug and device reimbursement, the pending Biosecure Act, and increased political frictions, China has announced 2 new policies to help increase foreign healthcare... Read More
Over the last 20 years, Western medical device makers have had a boom in device exports to Asia. During that time, most Asian countries’ populations have gotten wealthier, seen more government investment in healthcare, seen new, more and advanced healthcare insurance programs... Read More
In late July, Indonesia’s government announced GR 28 which is similar to the Indonesian Health Omnibus Law, but with more detailed explanations. This new regulation covers a number of topics. First, it states that the National Health Information System can use data... Read More
Japan’s medical device market is the third largest medical device market in the world, after the US and China. While it is a highly competitive market, unique products with good value propositions can be very successful there. While in the past Japan... Read More
As mentioned last year in our news brief, more and more Western drug companies are looking for new products in China. This trend has continued in 2024 as over 19 transactions valued at more than $18 billion USD were consummated in January... Read More